BRIEF-MediciNova says exploratory interim clinical outcomes data from clinical trial of MN-166 in ALS

* Says it announced exploratory interim clinical outcomes

data from clinical trial of MN-166 (ibudilast) in ALS presented

at the American Academy of Neurology (AAN) 69th Annual Meeting

in Boston

Read more